ArticleGynecologic oncology2015

Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo.

Carlton L Schwab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.